Vasily Shikin sold $33M of APP
Chief Technology Officer at AppLovin Corp. 68,035 shares at an average of $485.74, traded Mar 10, 2026, filed Mar 12, 2026.
Score components
- +15RoleOfficer
- +25Trade size$33.0M at market
- 0Share of holdings soldSold 2.1% of holdings
- +15Cluster4 insiders selling within 14 days
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m -12.9%, 3m +6.5%, 6m -30.0%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001847757-26-000005, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Mar 10, 2026 | SOpen-market sale Class A Common Stock10b5-1 | -5,817 | $474.78 | $2.8M | 3,312,260 | Mar 12, 2026 |
| Mar 10, 2026 | SOpen-market sale Class A Common Stock10b5-1 | -4,057 | $476.23 | $1.9M | 3,308,203 | Mar 12, 2026 |
| Mar 10, 2026 | SOpen-market sale Class A Common Stock10b5-1 | -17,779 | $477.56 | $8.5M | 3,290,424 | Mar 12, 2026 |
| Mar 10, 2026 | SOpen-market sale Class A Common Stock10b5-1 | -7,515 | $479.34 | $3.6M | 3,282,909 | Mar 12, 2026 |
| Mar 10, 2026 | SOpen-market sale Class A Common Stock10b5-1 | -1,445 | $481.00 | $695k | 3,281,464 | Mar 12, 2026 |
| Mar 10, 2026 | SOpen-market sale Class A Common Stock10b5-1 | -2,055 | $482.48 | $991k | 3,279,409 | Mar 12, 2026 |
| Mar 10, 2026 | SOpen-market sale Class A Common Stock10b5-1 | -532 | $484.78 | $258k | 3,278,877 | Mar 12, 2026 |
| Mar 10, 2026 | SOpen-market sale Class A Common Stock10b5-1 | -333 | $487.17 | $162k | 3,278,544 | Mar 12, 2026 |
| Mar 10, 2026 | SOpen-market sale Class A Common Stock10b5-1 | -2,047 | $489.40 | $1.0M | 3,276,497 | Mar 12, 2026 |
| Mar 10, 2026 | SOpen-market sale Class A Common Stock10b5-1 | -280 | $490.69 | $137k | 3,276,217 | Mar 12, 2026 |
| Mar 10, 2026 | SOpen-market sale Class A Common Stock10b5-1 | -1,624 | $493.25 | $801k | 3,274,593 | Mar 12, 2026 |
| Mar 10, 2026 | SOpen-market sale Class A Common Stock10b5-1 | -4,925 | $495.01 | $2.4M | 3,269,668 | Mar 12, 2026 |
| Mar 10, 2026 | SOpen-market sale Class A Common Stock10b5-1 | -2,915 | $496.62 | $1.4M | 3,266,753 | Mar 12, 2026 |
| Mar 10, 2026 | SOpen-market sale Class A Common Stock10b5-1 | -280 | $498.51 | $140k | 3,266,473 | Mar 12, 2026 |
| Mar 10, 2026 | SOpen-market sale Class A Common Stock10b5-1 | -840 | $500.64 | $421k | 3,265,633 | Mar 12, 2026 |
| Mar 10, 2026 | SOpen-market sale Class A Common Stock10b5-1 | -1,120 | $501.71 | $562k | 3,264,513 | Mar 12, 2026 |
| Mar 10, 2026 | SOpen-market sale Class A Common Stock10b5-1 | -954 | $503.17 | $480k | 3,263,559 | Mar 12, 2026 |
| Mar 10, 2026 | SOpen-market sale Class A Common Stock10b5-1 | -84 | $504.50 | $42k | 3,263,475 | Mar 12, 2026 |
| Mar 10, 2026 | SOpen-market sale Class A Common Stock10b5-1 | -1,035 | $506.47 | $524k | 3,262,440 | Mar 12, 2026 |
| Mar 10, 2026 | SOpen-market sale Class A Common Stock10b5-1 | -1,140 | $507.74 | $579k | 3,261,300 | Mar 12, 2026 |
| Mar 10, 2026 | SOpen-market sale Class A Common Stock10b5-1 | -484 | $508.82 | $246k | 3,260,816 | Mar 12, 2026 |
| Mar 10, 2026 | SOpen-market sale Class A Common Stock10b5-1 | -1,763 | $510.20 | $899k | 3,259,053 | Mar 12, 2026 |
| Mar 10, 2026 | SOpen-market sale Class A Common Stock10b5-1 | -1,036 | $511.28 | $530k | 3,258,017 | Mar 12, 2026 |
| Mar 10, 2026 | SOpen-market sale Class A Common Stock10b5-1 | -2,128 | $512.59 | $1.1M | 3,255,889 | Mar 12, 2026 |
| Mar 10, 2026 | SOpen-market sale Class A Common Stock10b5-1 | -616 | $514.43 | $317k | 3,255,273 | Mar 12, 2026 |
| Mar 10, 2026 | SOpen-market sale Class A Common Stockindirect: See footnote10b5-1 | -831 | $474.78 | $395k | 35,058 | Mar 12, 2026 |
| Mar 10, 2026 | SOpen-market sale Class A Common Stockindirect: See footnote10b5-1 | -580 | $476.22 | $276k | 34,478 | Mar 12, 2026 |
| Mar 10, 2026 | SOpen-market sale Class A Common Stockindirect: See footnote10b5-1 | -2,540 | $477.56 | $1.2M | 31,938 | Mar 12, 2026 |
| Mar 10, 2026 | SOpen-market sale Class A Common Stockindirect: See footnote10b5-1 | -1,073 | $479.34 | $514k | 30,865 | Mar 12, 2026 |
| Mar 10, 2026 | SOpen-market sale Class A Common Stockindirect: See footnote10b5-1 | -207 | $481.00 | $100k | 30,658 | Mar 12, 2026 |
Related signals
Other insiders at AppLovin Corp and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 20Weak | AppLovin Corp | Maynard G Webb Jr director | $1.6M 3,076 shares | -2% | |
| 35Weak | AppLovin Corp | Eduardo Vivas director | $83M 163,910 shares | -2% | |
| 65Notable | AppLovin Corp | Arash Adam Foroughi CEO | $15M 29,457 shares | -1% | |
| 65Notable | AppLovin Corp | Arash Adam Foroughi CEO | $25M 52,165 shares | -2% | |
| 65Notable | AppLovin Corp | Arash Adam Foroughi CEO | $11M 22,544 shares | -1% | |
| 55Moderate | AppLovin Corp | Victoria Valenzuela CALO & Corp. Secretary | $11M 20,000 shares | -8% | |
| 35Weak | AppLovin Corp | Maynard G Webb Jr director | $1.8M 3,076 shares | -2% | |
| 42Moderate | AppLovin Corp | Matthew Stumpf Chief Financial Officer (CFO) | $5.4M 9,052 shares | -5% | |
| 35Weak | AppLovin Corp | Vasily Shikin Chief Technology Officer | $34M 70,916 shares | -2% | |
| 55Moderate | AppLovin Corp | Vasily Shikin Chief Technology Officer | $7.7M 15,915 shares | -85% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.